Rovin Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $332K | Buy |
820
+101
| +14% | +$40.9K | 0.1% | 151 |
|
|
2025
Q1 | $358K | Buy |
719
+116
| +19% | +$57.8K | 0.12% | 136 |
|
|
2024
Q4 | $314K | Sell |
603
-65
| -10% | -$33.8K | 0.11% | 127 |
|
|
2024
Q3 | $413K | Buy |
668
+39
| +6% | +$24.1K | 0.15% | 115 |
|
|
2024
Q2 | $348K | Buy |
629
+70
| +13% | +$38.7K | 0.15% | 117 |
|
|
2024
Q1 | $325K | Buy |
+559
| New | +$325K | 0.13% | 115 |
|
|
2022
Q2 | – | Sell |
-346
| Closed | -$204K | – | 129 |
|
|
2022
Q1 | $204K | Sell |
346
-615
| -64% | -$363K | 0.11% | 116 |
|
|
2021
Q4 | $641K | Buy |
961
+603
| +168% | +$402K | 0.31% | 51 |
|
|
2021
Q3 | $205K | Buy |
+358
| New | +$205K | 0.14% | 62 |
|